GPC Biotech AG: Premium Company Profile

Introduction

GPC Biotech (GPC), founded in 1997, has a business model relied on two pillars, as a service provider for preclinical research and as a product company with its own development pipeline. Later, the company changed its focus by developing a platform of base technologies, LeadCode, through collaborations with pharmaceutical partners and through the support of its own drug development projects.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

GPC is a biopharmaceutical company focused on discovery, development and commercialization of new anticancer drugs, Cell Cycle Inhibitors and antibodies against MHC class II-positive tumor cells. It’s most advanced product candidate satraplatin is currently in SPARC Phase III trial, for the treatment of hormone-refractory prostate cancer. The company’s second lead product candidate, 1D09C3, is in Phase I clinical trials and is a monoclonal antibody indicated for the treatment of relapsed/refractory B-cell lymphomas, such as Hodgkin’s and non-Hodgkin’s lymphomas and chronic lymphocytic leukemia. The company’s total revenues increased at a CAGR of 1.3% during 2002-2006, from $27.6 million to $29.1 million. This represents an absolute total growth of +$1.5 million during the historical period. The company’s biggest contributor to revenue growth during 2002-2006 was license, collaboration and other revenues.

Reasons to Purchase

• Access all the important information and analysis on the company in a single report
• Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
• Gain access to company’s adjusted five year financial data along with key ratios and market capitalization.

TABLE OF CONTENTS
Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 9
Locations and Subsidiaries 12
Company Financials 13
Stock Market Performance 13
P&L 15
Balance Sheet 18
Cash Flow 18
Business Segment Performance 19
Products & Services 20
Pipeline Products 20
Competitors and Strategic Business Relationships 23
Key Competitors 23
Key Suppliers 24
Key Clients 25
Strategy 26
Company View 26
Corporate Strategy 29
SWOT Analysis 30
Overview 30
Strengths 31
Weaknesses 32
Opportunities 33
Threats 34
Value Chain Analysis 35
Overview 35
Discovery and Product Development 36
Key Employees 37
List of Key Employees 37
Key Employee Biographies 38
Financial and Operational Overview 43
Financial and Operational Overview 43
APPENDIX 45
Ask the analyst 45
Datamonitor consulting 45
Disclaimer 45


TABLE OF FIGURES
Figure 1: GPC - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 16


TABLE OF TABLES
Table 1: GPC - Key Facts 6
Table 2: GPC – Locations and Subsidiaries 12
Table 3: GPC - Year-End Share Price and Market Capitalization, 2002-2006 ($) 13
Table 4: GPC - Key Events Impacting Share Price Performance 14
Table 5: GPC - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15
Table 6: GPC - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 17
Table 7: GPC - Balance Sheet, 2002-2006 ($ Mn) 18
Table 8: GPC - Cash Flow, 2002-2006 ($ Mn) 18
Table 9: GPC - Revenue Breakdown by Division, 2002-2006 ($ Mn) 19
Table 10: GPC - In-house Pipeline Products 20
Table 11: GPC - Collaboration Products 21
Table 12: GPC - Key Competitors 24
Table 13: GPC - Key Suppliers 25
Table 14: GPC - Key Clients 25
Table 15: GPC - SWOT Analysis Summary 30
Table 16: GPC - Value Chain Analysis 35
Table 17: GPC - Key Employees 37
Table 18: GPC - Financial and Operational Overview 43